| An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE) (NCT01018238) | Novo Nordisk A/S | 2009-11-01 |
| Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study (NCT00911521) | Tuen Mun Hospital | 2009-10-01 |
| A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus (NCT00962832) | Genentech, Inc. | 2009-09-01 |
| The CARRA Registry (NCT01697254) | Duke University | 2009-08-01 |
| Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE) (NCT00997100) | Active Biotech AB | 2009-08-01 |
| Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76 (NCT01914770) | GlaxoSmithKline | 2009-07-01 |
| Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE) (NCT00987831) | Oklahoma Medical Research Foundation | 2009-05-01 |
| NOX-E36 First-in-Human (FIH) Study (NCT00976729) | TME Pharma AG | 2009-05-01 |
| Omega 3 Fatty Acids and Systemic Lupus Erythematosus (NCT02524795) | Federal University of Minas Gerais | 2009-03-01 |
| Efficacy of Fish Oil in Lupus Patients (NCT00828178) | Michelle Petri M.D.,MPH | 2009-02-01 |
| Autoimmunity in Sisters of Lupus Patients (NCT01076101) | Northwell Health | 2009-02-01 |
| Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease (NCT00815282) | N.M. Wulffraat | 2009-02-01 |
| A Study of AMG 557 in Adults With Systemic Lupus Erythematosus (NCT00774943) | Amgen | 2008-12-01 |
| Vitamin D3 in Systemic Lupus Erythematosus (NCT00710021) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women (NCT00786409) | University of Chicago | 2008-11-01 |
| Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus (NCT00752999) | Rigel Pharmaceuticals | 2008-11-01 |
| Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE) (NCT00732940) | Human Genome Sciences Inc. | 2008-10-01 |
| Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan (NCT00747578) | Taichung Veterans General Hospital | 2008-09-01 |
| A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States (NCT00724867) | Human Genome Sciences Inc., a GSK Company | 2008-08-01 |
| Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST) (NCT00750971) | Charite University, Berlin, Germany | 2008-08-01 |
| A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus (NCT00982670) | Far Eastern Memorial Hospital | 2008-07-01 |
| Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects (NCT02151409) | Novo Nordisk A/S | 2008-06-01 |
| A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057 (NCT00712933) | Human Genome Sciences Inc., a GSK Company | 2008-05-30 |
| The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria (NCT00508898) | Chinese University of Hong Kong | 2008-05-01 |
| Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease (NCT00660881) | UCB Pharma | 2008-05-01 |
| Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level (NCT00866229) | Ramathibodi Hospital | 2008-04-01 |
| A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) (NCT00626197) | Genentech, Inc. | 2008-02-15 |
| Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease (NCT00624351) | UCB Pharma | 2008-01-01 |
| A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN) (NCT00539838) | Genentech, Inc. | 2007-12-19 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus (NCT02291588) | Amgen | 2007-12-01 |
| The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) Study (NCT00671047) | XDx | 2007-12-01 |
| Insulin Resistance and Atherosclerosis in Women With Lupus (NCT00544102) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2007-10-11 |
| Pulse Corticosteroid Therapy and Effect on Brain Water Diffusivity (NCT00527176) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2007-09-01 |
| Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors (NCT00519363) | The Center for Rheumatic Disease, Allergy, & Immunology | 2007-09-01 |
| Duke Autoimmunity in Pregnancy Registry (NCT00513591) | Duke University | 2007-08-01 |
| Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus (NCT00479622) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study (NCT00522002) | George Washington University | 2007-08-01 |
| Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc) (NCT00684255) | New York Medical College | 2007-08-01 |
| Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus Erythematosus (NCT05146414) | Assistance Publique - Hôpitaux de Paris | 2007-07-10 |
| Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus (NCT04580108) | Assistance Publique - Hôpitaux de Paris | 2007-07-03 |
| Myfortic Versus Azathioprine in Systemic Lupus Erythematosus (NCT00504244) | Erasmus Medical Center | 2007-07-01 |
| Duke Lupus Registry (NCT00512694) | Duke University | 2007-07-01 |
| The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS (NCT00413361) | Assistance Publique - Hôpitaux de Paris | 2007-06-01 |
| Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis (NCT00430677) | Bristol-Myers Squibb | 2007-06-01 |
| Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus (NCT00668330) | Chinese University of Hong Kong | 2007-04-01 |
| Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus (NCT01322308) | National Heart Institute, Mexico | 2007-03-01 |
| An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus (NCT00432354) | Buddhist Tzu Chi General Hospital | 2007-03-01 |
| A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus (NCT00541749) | Genentech, Inc. | 2007-02-01 |
| Study of Epratuzumab in Systemic Lupus Erythematosus (NCT00382837) | UCB Pharma | 2007-01-01 |
| Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE) (NCT00418587) | Medical University of South Carolina | 2006-12-01 |
| Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus (NCT00723671) | University of Michigan | 2006-11-01 |
| A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus (NCT02391259) | Amgen | 2006-11-01 |
| Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis (NCT00594932) | Oklahoma Medical Research Foundation | 2006-11-01 |
| Cyclophosphamide in Lupus Nephritis (NCT00441220) | University of Auckland, New Zealand | 2006-10-01 |
| Study of LJP 394 (Abetimus Sodium) in Lupus Patients (NCT00390091) | La Jolla Pharmaceutical Company | 2006-09-01 |
| Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus (NCT00858884) | University of New Mexico | 2006-08-01 |
| Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus (NCT00371501) | Tuen Mun Hospital | 2006-06-01 |
| Study of Epratuzumab in Systemic Lupus Erythematosus (NCT00383513) | UCB Pharma | 2006-06-01 |
| Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus (NCT00556192) | Chinese University of Hong Kong | 2006-06-01 |
| Memantine in Systemic Lupus Erythematosus (NCT00181298) | Johns Hopkins University | 2006-03-01 |
| Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) (NCT01101802) | Guy's and St Thomas' NHS Foundation Trust | 2006-03-01 |
| Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil (NCT00297284) | Hospital for Special Surgery, New York | 2006-02-01 |
| Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus (NCT00278538) | Northwestern University | 2005-09-23 |
| Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) (NCT00230035) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone (NCT00119678) | Bristol-Myers Squibb | 2005-09-01 |
| Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) (NCT00172666) | National Taiwan University Hospital | 2005-08-01 |
| A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus (NCT00203151) | Teva Branded Pharmaceutical Products R&D, Inc. | 2005-07-01 |
| Study of Epratuzumab in Systemic Lupus Erythematosus (NCT00111306) | UCB Pharma | 2005-06-01 |
| A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02 (NCT00583362) | Human Genome Sciences Inc., a GSK Company | 2005-05-04 |
| A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus (NCT02411136) | Amgen | 2005-05-01 |
| Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) (NCT00383214) | UCB Pharma | 2005-05-01 |
| Aspirin Resistance in Systemic Lupus Erythematosus (SLE) (NCT00731302) | Vanderbilt University | 2005-04-01 |
| Estrogen and Gender Biased Autoimmunity (NCT00519454) | The Center for Rheumatic Disease, Allergy, & Immunology | 2005-04-01 |
| Feasibility and Safety of Acupuncture for Systemic Lupus (NCT00493753) | University of Pittsburgh | 2004-11-01 |
| A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus (NCT02443506) | Amgen | 2004-10-01 |
| Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies (NCT00417430) | The Center for Rheumatic Disease, Allergy, & Immunology | 2004-09-01 |
| Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus (NCT00278590) | Northwestern University | 2004-07-01 |
| Health-related Quality of Life Measure in Pediatric Lupus (NCT00280137) | Rutgers, The State University of New Jersey | 2004-06-01 |
| Abnormalities of B Lymphocytes During Systemic Lupus (NCT00401141) | University Hospital, Strasbourg, France | 2004-04-01 |
| Effects of Treatment of Chronic Stress in Patients With Lupus (NCT00483613) | University Hospital Virgen de las Nieves | 2003-12-01 |
| Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases (NCT00069342) | National Institutes of Health Clinical Center (CC) | 2003-09-22 |
| Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention (NCT00189124) | University of Michigan | 2003-09-01 |
| Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) (NCT00198068) | Hospital for Special Surgery, New York | 2003-09-01 |
| HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus (NCT00188357) | University Health Network, Toronto | 2003-08-01 |
| GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids (NCT00082511) | Genelabs Technologies | 2003-07-01 |
| Triptorelin for Ovary Protection in Childhood Onset Lupus (NCT00124514) | Children's Hospital Medical Center, Cincinnati | 2003-06-01 |
| Study of Families With Twins or Siblings Discordant for Rheumatic Disorders (NCT00055055) | National Institute of Environmental Health Sciences (NIEHS) | 2003-04-21 |
| Systemic Lupus Erythematosus in Gullah Health (NCT00756769) | Medical University of South Carolina | 2003-04-01 |
| Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) (NCT00054938) | Brigham and Women's Hospital | 2003-03-01 |
| Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases (NCT00849745) | Duke University | 2003-01-01 |
| Monoclonal Antibody Treatment for Systemic Lupus Erythematosus (NCT00046774) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2002-09-02 |
| Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study (NCT00271934) | Northwestern University | 2002-09-01 |
| Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus (NCT00042523) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2002-07-01 |
| Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis (NCT02408471) | Smith & Nephew, Inc. | 2002-06-01 |
| Lupus Atherosclerosis Prevention Study (NCT00120887) | Johns Hopkins University | 2002-04-01 |
| Skin Denervation in Systemic Lupus Erythematosus (NCT00155532) | National Taiwan University Hospital | 2002-04-01 |
| Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease (NCT00188188) | University Health Network, Toronto | 2002-03-01 |
| Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis (NCT00293072) | Cambridge University Hospitals NHS Foundation Trust | 2002-03-01 |
| Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) (NCT00657007) | Human Genome Sciences Inc. | 2002-02-01 |
| Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study (NCT00976300) | Institute of Rheumatology, Prague | 2002-01-01 |